Association of C-Reactive Protein and Other Markers of Inflammation with Risk of Complications in Diabetic Subjects.

about

Association of C-Reactive Protein and Other Markers of Inflammation with Risk of Complications in Diabetic Subjects.

Item

http://www.wikidata.org/entity/Q55221890

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Association of C-Reactive Prot ...... ications in Diabetic Subjects.

@en

Association of C-Reactive Prot ...... ications in Diabetic Subjects.

@nl

type

Item

label

Association of C-Reactive Prot ...... ications in Diabetic Subjects.

@en

Association of C-Reactive Prot ...... ications in Diabetic Subjects.

@nl

prefLabel

Association of C-Reactive Prot ...... ications in Diabetic Subjects.

@en

Association of C-Reactive Prot ...... ications in Diabetic Subjects.

@nl

P1476

Association of C-Reactive Prot ...... ications in Diabetic Subjects.

@en

P2093

Aneta Mankowska

http://www.w3.org/2001/XMLSchema#string

Grazyna Sypniewska

http://www.w3.org/2001/XMLSchema#string

Joanna Pollak

http://www.w3.org/2001/XMLSchema#string

P2860

High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease

Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans.

The association of serum lipids and inflammatory biomarkers with renal function in men with type II diabetes mellitus.

C-reactive protein as a novel biomarker. Reactant can flag atherosclerosis and help predict cardiac events.

Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease.

Diabetes and inflammation.

The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease.

Comparison of insulin resistance and serum high-sensitivity C-reactive protein levels according to the fasting blood glucose subgroups divided by the newly recommended criteria for fasting hyperglycemia in 10059 healthy Koreans.

Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus.

Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus.

P304

8-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29795716

http://www.w3.org/2001/XMLSchema#string

P932

5954428

http://www.w3.org/2001/XMLSchema#string